Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Purified Isoflavones in Prostate Cancer
NCT01036321Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Dec 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Hizofito in prostate cancer (PCa) (2 arms), sponsored by Moffitt Cancer Center. Primary endpoints: Median Change in Percent Ki-67 From Baseline up to 6 weeks and Number of Toxicity Events by Final Attribution and Treatment Arm up to 6 weeks. Started Dec 2009; status: completed.
02
Drugs
Hizofito
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01036321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01036321.